期刊文献+

DWI评价兔VX2移植瘤转移淋巴结放疗的早期疗效 被引量:1

DWI evaluation on early response to radiotherapy in rabbit models bearing VX2 with lymph node metastasis
下载PDF
导出
摘要 目的探讨DWI对评价转移淋巴结早期放疗疗效的价值。方法建立转移性淋巴结动物模型,随机分为放疗组(16枚淋巴结)与对照组(10枚淋巴结),分别于放疗前、后第1、3、7天进行常规MR及DWI检查,测量淋巴结的体积和ADC值。对两组淋巴结ADC值采用重复测量数据的方差分析。对每个时间点两组淋巴结体积和ADC值行独立样本t检验。结果放疗组4枚淋巴结第7天出现坏死,呈长T1、T2信号,且放疗后第1天淋巴结ADC值下降(1.04±0.17)×10-3mm2/s,第3、7天逐渐升高[(1.27±0.20)×10-3mm2/s、(1.69±0.33)×10-3mm2/s]。放疗后第7天两组淋巴结ADC值差异有统计学意义(F=17.87,P<0.05),放疗后第3、7天ADC值与放疗前及放疗后第1天ADC值差异有统计学意义(P均<0.05)。结论 ADC值能用于观测动物转移性淋巴结的早期放疗反应。 Objective To observe the value of DWI in monitoring lymph node metastasis early response to radiotherapy.Methods Animal models of lymph node metastasis were divided into irradiation group(16 lymph nodes) and control groups(10 lymph nodes).MRI and DWI were performed respectively before and 1,3,and 7 days after irradiation in all rabbits.The volumes and ADC values of lymph nodes were measured,and the variants were evaluated with repeated measures ANOV.At each time interval,the Student's t test was used to assess differences between two groups.Results In irradiation group,necrosis was found in 4 nodes 7 days after therapy.Necrosis revealed hypointensity on T1WI and hyperintensity on T2WI.ADC values of all nodes adopted irradiation decreased 1 day after therapy(1.04±0.17)×10-3 mm2/s,then ADC values increased gradually([1.27±0.20]×10-3 mm2/s and [1.69±0.33]×10-3 mm2/s) 3 days and 7 days later.Significant difference of variation of ADC values between two groups present 7 days after therapy(F=17.87,P〈0.05).In irradiation group,3 and 7 days after therapy,ADC values were significantly higher than pre-treatment and 1 day after therapy(both P〈0.05).Conclusion ADC values can be used to observe early radiation response in animal models.
出处 《中国医学影像技术》 CSCD 北大核心 2011年第5期891-894,共4页 Chinese Journal of Medical Imaging Technology
基金 江苏省卫生厅科技计划(H200647) 上海市科委科技合作基金(08210707600)
关键词 淋巴转移 扩散磁共振成像 Lymphatic metastasis Diffusion magnetic resonance imaging
  • 相关文献

参考文献4

二级参考文献27

  • 1孙应实,张晓鹏,唐磊.直肠癌扩散加权成像b值选取及其对直肠癌显示能力的评价[J].中国医学影像技术,2005,21(12):1839-1843. 被引量:44
  • 2Zambon L, Honma HN, Lourenco GJ, et al. A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility. Lung Cancer, 2008,59(2) :276-278.
  • 3Yokoyama Y, Sedgewick G, Ramakrishnan S. Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination. Cancer Res, 2007,67(22) : 10813-10822.
  • 4Book NA, Konyer NB, Henkelman RM. Multiple-mouse MRI. Magn Reson Med, 2003,49(1):158-167.
  • 5Galloway NR, Tong KA, Ashwal S, et al. Diffusion weighted imaging improves outcome prediction in pediatric traumatic brain injury. J Neurotrauma, 2008,25(10):1153-1162.
  • 6Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol, 2000, 29 (10) : 555-562.
  • 7Kim JH, Kim JK, Park BW, et al. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging, 2008,28(5) : 1173-1179.
  • 8Farrell JA, Smith SA, Gordon Lipkin EM, et al. High b-value q-space diffusion weighted MRI of the human cervical spinal cord in vivo: feasibility and application to multiple sclerosis. Magn Reson Med, 2008,59(5) :1079 -1089.
  • 9Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology, 2005,234(3):756- 764.
  • 10Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther, 2003,2(6) : 581-587.

共引文献97

同被引文献9

  • 1Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res, 1997, 3: 1457-1466.
  • 2Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology, 2005, 234: 756-764.
  • 3Ross BD, Moffat BA, Lawrence TS, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther, 2003, 2: 581-587.
  • 4Chenevert TL, Meyer CR, Moffat BA, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging, 2002, 1: 336-343.
  • 5Holzapfel K, Duetseh S, Fauser C, et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol, 2009, 72: 381-387.
  • 6Wisner ER, Th6on AP, Katzberg RW, et al. Lymph node uptake of interstitially delivered particulate contrast media before and after irradiation in dogs. Acad Radiol, 1999, 6:119-25.
  • 7Bekierkunst A, Levij IS, Yarkoni E, et al. Cellular reaction in the footpad and draining lymph nodes of mice induced by mycobacterial fractions and BCG bacilli. Infect Immun, 1971, 4: 245-55.
  • 8Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high- grade astrocytomas: comparison of water diffusibility and )istologic characteristics. Radiology, 2002, 224: 177-183.
  • 9周国兴,郝楠馨,张蕾,诸静其,潘海虹,王军臣,卢爱国.直肠周围间隙淋巴结转移的术前MSCT评估[J].中国医学计算机成像杂志,2010,16(1):25-30. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部